Finerenone, BAY 94-8862, BAY 948862, Finerenone Bayer
20186
Phase 3 small_molecule active
Quick answer
Finerenone, BAY 94-8862, BAY 948862, Finerenone Bayer for Treatment of children with chronic kidney disease and proteinuria is a Phase 3 program (small_molecule) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- Treatment of children with chronic kidney disease and proteinuria
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active